Retagliptin phosphate salt form · phosphate · Parent Retagliptin phosphate · Synonyms: SP2086 phosphate
Retagliptin phosphate is a selective, competitive and orally active dipeptidyl peptidase-4 inhibitor.
For research use only. Not for human or veterinary use.
Target
Dipeptidyl Peptidase
Research area
Metabolic Disease
Purity >98%
Stock Inquire
Retagliptin phosphate structure
CAS No.: 1256756-88-3
Pack sizes & pricing
Description
Retagliptin phosphate (SP2086 phosphate) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. Retagliptin phosphate can be used for type 2 diabetes mellitus (T2DM) research.
Biological activity
In Retagliptin is a class of compound used for research of type 2 diabetes. Retagliptin inhibits the degradation of GLP-1, thus amplifying the incretin effect.
Identifiers
- SMILES
-
OP(O)(O)=O.COC(=O)C1=C2CN(CCN2C(=N1)C(F)(F)F)C(=O)C[C@H](N)CC1=CC(F)=C(F)C=C1F - InChIKey
-
SFNHOWDAQMIJPX-HNCPQSOCSA-N
Specifications
- MW (average)
- 562.3568
- Formula
- C19H21F6N4O7P
- CAS No.
- 1256756-88-3
- Physical state
- Solid
- Color
- white to light yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃ 2 years; In solvent -20℃ 1 month;
Solubility
Soluble in DMSO
Documents
References
[1]. Hu C, et al. Pharmacokinetics of Phosphate Retagliptin Tabletin in Patients with Renal Dysfunction. Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 Jan;49(1):74-80.
[2]. Avivit Cahn, et al. An update on DPP-4 inhibitors in the management of type 2 diabetes. Expert Opin Emerg Drugs. 2016 Dec;21(4):409-419.
Same target
Search Dipeptidyl PeptidaseSame research area
Search Metabolic Disease- BP-00002A Petrelintide acetate salt · >98%
- BP-00002 Petrelintide free base · >98%
- BP-00103 Nisotirostide free base · >98%
- BP-00756 PF-07853578 free base · >98%
- BP-00906 TYRA-300 free base · >98%
- BP-01096 PROTAC AR Degrader-5 free base · >98%
- BP-01635 PF-04620110 free base · >98%
- BP-01673 Casein Kinase II Inhibitor IV free base · >98%